ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentur, L.
Right arrow Articles by Gavriely, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentur, L.
Right arrow Articles by Gavriely, N.
Eur Respir J 2003; 21:621-626
Copyright ©ERS Journals Ltd 2003


Wheeze monitoring in children for assessment of nocturnal asthma and response to therapy

L. Bentur1,2, R. Beck1, M. Shinawi1, T. Naveh1 and N. Gavriely2

1 Division of Paediatric Pulmonology, Rambam Medical Centre and 2 Pulmonary Physiology Section, The Bruce Rappaport Faculty of Medicine at Technion - Israel Institute of Technology, Haifa, Israel

CORRESPONDENCE: N. Gavriely, Pulmonary Physiology Section, The Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, P.O. Box 9697, Haifa, 31096, Israel. Fax: 972 48533185. E-mail: gavriely@tx.technion.ac.il

Keywords: asthma monitoring, automatic wheeze detection, breath sounds, leukotriene receptor antagonist, nocturnal asthma, pulmonary acoustics

Received: May 1, 2002
Accepted November 11, 2002

This study was funded in part by grants from Merck, Sharp & Dohme (MSD), Israel and by Karmel Medical Acoustic Technologies Ltd, Yokneam Illit, Israel.

The utilisation of nocturnal wheeze monitoring and quantification for assessment of asthma activity was studied in symptomatic school-aged children before and during treatment.

Twelve children 6–14 yrs of age with mild or moderate untreated asthma were studied at home three times: before, 48 h and 6 weeks into treatment with 5 mg montelukast daily. Lung sounds were recorded overnight by an automatic wheeze detection device (PulmoTrack®). Per cent wheezing within each respiratory cycle was calculated every 30 s throughout the night and a Nocturnal Wheeze Index (NWI) was calculated for the total night. The results were compared with spirometric indices (forced expiratory volume in one second (FEV1), forced vital capacity), bronchial reactivity (provocative concentration causing a 20% fall in FEV1 by adenosine 5'-monophosphate (PC20)) and daily symptom scores, performed in parallel at each stage of the study.

The pretreatment NWI was 814±898 (mean±sd), which declined to 318±199 2 days after onset, and to 137±101 after 6 weeks of treatment. The NWI in seven healthy children was 47±43. The FEV1, PC20 and symptom scores improved in parallel.

Wheeze monitoring provides quantitative and noninvasive information about the extent of nocturnal wheezing in children, correlates well with conventional indices of asthma activity and can assist in assessing efficacy of treatment.




This article has been cited by other articles:


Home page
ChestHome page
L. Bentur, R. Beck, D. Berkowitz, J. Hasanin, I. Berger, N. Elias, and N. Gavriely
Adenosine Bronchial Provocation With Computerized Wheeze Detection in Young Infants With Prolonged Cough: Correlation With Long-term Follow-up
Chest, October 1, 2004; 126(4): 1060 - 1065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.